Paclitaxel-induced FasL-independent apoptosis and slow (non-apoptotic) cell death

Mikhail V Blagosklonny1, Robert Robey, M Saeed Sheikh

  • 1Medicine Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA. M_Blagosklonny@NYMC.Edu

Cancer Biology & Therapy
|August 13, 2002
PubMed

Insights

Paclitaxel (PTX) causes cell death, but its mechanism differs by cell type. PTX-induced apoptosis in Jurkat cells is FasL-independent, while MDA-MB-231 cells undergo slower, non-apoptotic death after mitotic arrest.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Pharmacology

Background:

  • Microtubule-active drugs like paclitaxel (PTX) induce mitotic arrest, potentially leading to apoptosis.
  • Previous studies suggested PTX mediates apoptosis via FasL upregulation in Jurkat and MDA-231 cells.

Purpose of the Study:

  • To investigate the role of FasL in paclitaxel-induced apoptosis in Jurkat and MDA-231 cells.
  • To elucidate the distinct mechanisms of cell death induced by PTX in different cell lines.

Main Methods:

  • Treatment of Jurkat and MDA-231 cells with paclitaxel (PTX) and anti-FasL antibodies.
  • Assessment of apoptosis induction, caspase activation (caspase-3, -8), and PARP cleavage.
  • Evaluation of cell fate following PTX-induced mitotic arrest, including multinucleation.

Main Results:

  • Anti-FasL antibodies did not inhibit PTX-induced apoptosis in Jurkat cells.
  • PTX did not induce apoptosis in MDA-231 cells; instead, it caused slow cell death without caspase activation or PARP cleavage.
  • Doxorubicin inhibited PTX-induced apoptosis in Jurkat cells but not FasL-induced apoptosis.
  • Jurkat cells underwent apoptosis after PTX-induced mitotic arrest, while MDA-MB-231 cells formed multinucleated cells and died via a non-apoptotic pathway.

Conclusions:

  • Paclitaxel-induced apoptosis in Jurkat cells is independent of the FasL pathway.
  • MDA-MB-231 cells exhibit a distinct, slower, non-apoptotic cell death mechanism following PTX-induced mitotic arrest.
  • Cellular response to paclitaxel varies, highlighting different cell death pathways activated by mitotic arrest.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.